Haihe biopharma 중국
WebOct 14, 2024 · Haihe Biopharma Co., Ltd. ClinicalTrials.gov Identifier: NCT04586335 Other Study ID Numbers: CYH33-G102 : First Posted: October 14, 2024 Key Record Dates: … WebMar 26, 2024 · Haihe Biopharma is a biopharmaceutical business that focuses on the development of anti-cancer medications. Details of the startup: Country: China; City: Shanghai; Started in: 2011; Founders: Jian Ding; Number of employees: 251-500; Funding amount: $317,605,942 ; Number of funding rounds: 2; Number of investors: 16; You can …
Haihe biopharma 중국
Did you know?
WebSep 16, 2024 · 대화제약은 중국 파트너사인 하이헤 바이오팜(Haihe Biopharma)과 함께 중국에서 3상 임상시험을 진행했다. 이를 바탕으로 허가를 신청해 수리 통보를 받았다. WebFeb 5, 2024 · Haihe Biopharma Co., Ltd. ClinicalTrials.gov Identifier: NCT04254471 Other Study ID Numbers: AL3810-301 : First Posted: February 5, 2024 Key Record Dates: Last Update Posted: February 5, 2024 Last Verified: January 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ...
WebNov 3, 2024 · HONG KONG – Haihe Pharmaceutical Co. Ltd. has outsourced the China rights to its non-opioid analgesics candidates, RMX-1001 and RMX-1002, to 3D … http://m.yakup.com/news/index.html?mode=view&pmode=clist&cat=all&cat2=&cat3=&nid=220584&num_start=58752
WebSep 14, 2024 · 대화제약과 중국 하이허 바이오파마(Haihe Biopharma, 海和药物)는 파클리탁셀 내용액제(이하 리포락셀)의 중국 NDA 신청이 … WebHaihe Biopharma contact info: Phone number: +86 2120568888 Website: www.haihepharma.com What does Haihe Biopharma do? Haihe Biopharma is an …
WebFeb 10, 2024 · Haihe Biopharma Co., Ltd. ClinicalTrials.gov Identifier: NCT04746612 Other Study ID Numbers: HH30134-G101 : First Posted: February 10, 2024 Key Record Dates: Last Update Posted: March 30, 2024 Last Verified: December 2024 Individual Participant Data (IPD) Sharing Statement: ...
Web대화제약의 알파이자 오메가, 세계 최초로 개발했다는 경구용 파클리탁셀 제제, 리포락셀의 중국 허가 신청 소식과 함께 tracy lynn abbottWebMar 7, 2024 · Haihe Biopharma Co., Ltd. ClinicalTrials.gov Identifier: NCT03457532 Other Study ID Numbers: SCC244-104 : First Posted: March 7, 2024 Key Record Dates: Last Update Posted: March 9, 2024 Last Verified: February 2024 tracy l. walsh mdWeb대화제약㈜은 세계 최초 경구용 파클리탁셀 ‘리포락셀®’의 미국 유방암 2상 임상시험(OPERA study) 첫 환자가 등록(미국 현지 24일)돼 임상시험이 본격적으로 시작됐다고 25일 밝혔다. 이 임상시험... the royal scotsman hotel edinburghWebBefore joining in Haihe Biopharma, I have conducted drug development in academia, multi-national pharmaceutical and startup biotech companies for 12 years after PhD training. The founder and senior management team of Haihe Biopharma created this company for real innovate drug development, with a dream of providing better therapeutics to ... tracy lynn abbott 43WebSep 14, 2024 · 14일 오후 2시 19분 현재 대화제약은 전일대비 1740원(24.86%) 상승한 8740원에 거래 중이다. 이 날 대화제약과 중국 하이허 바이오파마(Haihe Biopharma)는 ... tracy lynn adamsWebDec 13, 2024 · HH2710 is developed by Shanghai Haihe Pharmaceutical Co., Ltd. HH2710 is a highly potent, selective, reversible, ATP-competitive ERK1/2 inhibitor. This is a first-in-human study of HH2710 and is designed as an open-label, multicenter, Phase I/II study which is composed of a Phase I dose escalation and dose expansion stage and a Phase … the royal scottish pipers societyWebJul 27, 2024 · Shanghai, 27 July 2024— Shanghai Haihe Pharmaceutical Co., Ltd (referred as “Haihe Pharmaceutical” or the “Company”), a leading biotech company focusing on … the royal scots museum